Pu T - Search Results

1

External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.

Pu T, Shui R, Shi J, Liang Z, Yang W, Bu H, Li Q, Zhang Z; China Anticancer Association Professional Committee of Tumour Pathology. Pu T, et al. BMC Cancer. 2019 Oct 22;19(1):978. doi: 10.1186/s12885-019-6210-3. BMC Cancer. 2019. PMID: 31640622 Free PMC article.

2

[Ki-67 expression and its effect on response to neo-adjuvant chemotherapy in invasive breast cancer].

Wei XX, Zhang R, Pu TJ, Yang LB, Ye F, Bu H. Wei XX, et al. Among authors: pu tj. Zhonghua Bing Li Xue Za Zhi. 2017 Dec 8;46(12):817-821. doi: 10.3760/cma.j.issn.0529-5807.2017.12.001. Zhonghua Bing Li Xue Za Zhi. 2017. PMID: 29224273 Chinese.

3

Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.

Pu T, Guo P, Qiu Y, Chen S, Yang L, Sun L, Ye F, Bu H. Pu T, et al. Int J Clin Exp Pathol. 2015 Sep 1;8(9):10565-74. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617766 Free PMC article.

4

Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy.

Yang L, Zhong X, Pu T, Qiu Y, Ye F, Bu H. Yang L, et al. Among authors: pu t. World J Surg Oncol. 2018 Mar 7;16(1):51. doi: 10.1186/s12957-018-1332-7. World J Surg Oncol. 2018. PMID: 29514654 Free PMC article.

5

The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines.

Yang L, Chen M, Pu T, Wu S, Wei B, Yang J, Bu H, Zhang Z. Yang L, et al. Among authors: pu t. J Clin Pathol. 2020 May;73(5):283-290. doi: 10.1136/jclinpath-2019-206222. Epub 2019 Nov 15. J Clin Pathol. 2020. PMID: 31732618

6

Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast.

Lei T, Pu T, Wei B, Fan Y, Yang L, Shen M, Chen M, Yang J, Zhang Y, Zhang Z, Bu H. Lei T, et al. Among authors: pu t. J Clin Pathol. 2022 Jan;75(1):18-23. doi: 10.1136/jclinpath-2020-206468. Epub 2020 Nov 19. J Clin Pathol. 2022. PMID: 33214199

7

Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.

Chen M, Pu T, Wei B, Bu H, Tang P, Zhang Z. Chen M, et al. Among authors: pu t. Pathol Res Pract. 2022 Mar;231:153790. doi: 10.1016/j.prp.2022.153790. Epub 2022 Jan 29. Pathol Res Pract. 2022. PMID: 35158121

8

Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.

Zhang Y, Luo X, Chen M, Yang L, Lei T, Pu T, Wei B, Bu H, Zhang Z. Zhang Y, et al. Among authors: pu t. Breast Cancer Res Treat. 2022 Jul;194(2):279-295. doi: 10.1007/s10549-022-06627-y. Epub 2022 Jun 6. Breast Cancer Res Treat. 2022. PMID: 35666367

9

The expression of aldehyde dehydrogenase family in breast cancer.

Qiu Y, Pu T, Li L, Cheng F, Lu C, Sun L, Teng X, Ye F, Bu H. Qiu Y, et al. Among authors: pu t. J Breast Cancer. 2014 Mar;17(1):54-60. doi: 10.4048/jbc.2014.17.1.54. Epub 2014 Mar 28. J Breast Cancer. 2014. PMID: 24744798 Free PMC article.

10

Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p.

Li S, Pu T, Xiao L, Gao H, Li L, Ye F, Liu Y, Bu H. Li S, et al. Among authors: pu t. J Breast Cancer. 2019 Mar;22(1):52-66. doi: 10.4048/jbc.2019.22.e4. J Breast Cancer. 2019. PMID: 30941233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters